Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Opinion · 30 Sep 2024 Opinion · 27 Sep 2024 Evaluating the Efficacy of GLP-1 Agonists in Weight Loss Strategies for Obesity
Commentary · 28 Aug 2024 Expanding the Benefits of GLP-1 Agonists in Type 2 Diabetes: More Than Just Blood Sugar Control
Editorial · 25 Mar 2024 The Future of Obesity Treatment: GLP-1 Receptor Agonists in Non-Diabetic Populations
Rapid communication · 25 Mar 2024 Comparing GLP-1 Agonists: Efficacy, Safety, and Patient Compliance
Editorial · 25 Mar 2024 Beyond Blood Sugar: Cardiovascular and Weight Loss Benefits of GLP-1 Agonists
Commentary · 25 Mar 2024 GLP-1 Receptor Agonists: A Breakthrough in Type 2 Diabetes Management
Opinion · 6 Nov 2023 The Role of GLP-1 and Insulin in Metabolic Sensing
Perspective · 28 Mar 2022 GLP-1 Receptor Antagonists in Neurodegeneration: The Role of the Neurovascular Unit in Animals
Editorial · 30 Jul 2021 Type 2 Diabetes patients and their Glucagonostatic potency (GLP-1)
Editorial · 28 Jun 2021 GLP-1RA and DPP-4i and Heart Rat
Author(s): Johnrgronald* Full-Text PDF Select your language of interest to
Short communication · 2 Mar 2018 Treatment of type 2 diabetes, GLP-1 Agonist and a DPP-4 Inhibitor
Conference abstract · 2018 Preparation of Ganoderma lucidum polysaccharide loaded sodium alginate particles with nanoscaled surface morphology for controlled release
Ganoderma lucidum polysaccharide (GLP) is a functional food source deployed in preventative medicine. However, applications utilizing GLP are limited due to oxidative and acidic environmental damage. Advances in…
Conference abstract · 13 Jul 2015 Liraglutide protects high fat high sucrose diet induced obesity through elevation of energy expenditure
factor for type 2 diabetes, coronary heart disease, and stroke. Glucagon like peptide -1 (GLP-1) is synthesized by the L cells of ileal mucosa and is released after nutrients ... ingestion. GLP-1 potentiates…
Conference abstract · 2015 Buccal delivery of the GLP-1 against exenatide using ArisCrown technology
Arisgen has developed a novel lipid based formulation technology that can concomitantly

